Drugmakers monitor emergence of a new influenza A strain

Published: 2009-04-30 07:00:00

Updated: 2009-04-30 07:00:00

Domestic and foreign pharmaceutical companies are closely monitoring the situation regarding the emergence of swine flu that broke out in Mexico recently and spread to other nations such as the United States, Canada and Europe, costing more than 150 lives. A suspected case was also spotted in Kor...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK